Australia's most trusted
source of pharma news
Saturday, 27 April 2024
Posted 29 June 2022 AM
Boehringer Ingelheim (BI) has appointed Rebecca Mojsin to the newly-created role of Head of Corporate Affairs ANZ, wooing her away from Sanofi where she has worked for more than a decade.
It follows a recent review of the global function which resulted in a new structure that fully integrates Communications, Public & Government Affairs and Corporate Brand, according to BI.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.